Brainstorm Cell Therapeutics | BCLI - Current Assets


Brainstorm Cell Therapeutics reported $508K in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Alterity Therapeutics Limited AUD 27.05M 6.16M Jun/2023
Biogen USD 8.97B 37.5M Dec/2025
Brainstorm Cell Therapeutics USD 508K 1.01M Sep/2025
Cipla INR 249.18B 16.3B Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 88.92M 8.72M Sep/2025
CSL USD 11.85B 1000K Dec/2025
Cytokinetics USD 916.97M 60.37M Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
Grifols EUR 6.28B 92.48M Sep/2025
Halozyme Therapeutics USD 825.21M 503.54M Dec/2025
Mesoblast USD 202.48M 1.87M Dec/2025